Engineered Bacteria‐Vesicle Delivered Lactate Reprogramming Boosts Tumor Radiosensitivity
Advanced Science · 2026-03 · 13 (16)
DOI: 10.1002/advs.202524303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 04.01.2026. Verfasst von Fei Peng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection & School for Radiolog…. Hauptthemen laut MEDLINE: Radiation Tolerance, Escherichia coli, Lactic Acid, Colorectal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of the Jiangsu Higher Education Institutions of China, Interdisciplinary Basic Frontier Innovation Program of Suzhou Medical College of Soochow University, Key Laboratory of Radiation Damage and Treatment of Jiangsu Provincial Universities and Colleges.
Abstract (Originalsprache)
Radiotherapy (RT) remains a cornerstone in cancer treatment, yet its efficacy is often compromised by tumor‐acquired radioresistance, driven in part by lactate accumulation in the tumor microenvironment (TME). Lactate fosters therapeutic resistance through aberrant DNA repair, immunosuppression, and metabolic reprogramming, posing a formidable clinical challenge. Here, we report a precision microbial therapy leveraging engineered Escherichia coli Nissle 1917 (EcNΔ nlpI IHCL , ENHL) to target and deplete lactate in the TME. By utilizing engineered bacteria with nlpI gene deletion to enhance outer membrane vesicles (OMVs) biogenesis and introducing a bifunctional surface display system (INP‐HlpA for tumor targeting and ClyA‐EGFP for tracking), ENHL delivers lactate oxidase (LOx) to neutralize acidic stress. In vitro and in vivo studies confirm that ENHL and LOx‐loaded OMVs effectively radiosensitize colorectal cancer cells by depleting tumor‐derived and radiation‐induced lactate. Oral administration of ENHL selectively colonizes tumors, where arabinose induction triggers localized LOx expression, significantly improving radiosensitivity and immune cell infiltration while modulating gut microbiota. This synergistic approach—combining targeted metabolic modulation with microbial precision therapy—represents a transformative strategy to overcome RT resistance in colorectal cancer, offering a promising pathway toward clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection & School for Radiological and Interdisciplinary Sciences (RAD-X), the First Affiliated Hosp…
Förderung
- Natural Science Foundation of the Jiangsu Higher Education Institutions of China
- Interdisciplinary Basic Frontier Innovation Program of Suzhou Medical College of Soochow University
- Key Laboratory of Radiation Damage and Treatment of Jiangsu Provincial Universities and Colleges
- Suzhou Fundamental Research Project
- Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions
- Jiangsu Provincial Key Research and Development Program
- Innovative Research Group Project of the National Natural Science Foundation of China
Zitieren
APA
Peng, F., Lei, Z., Zhang, Z., Su, Z., Zhang, C., Yang, H., Liu, S., Hu, M., Wang, Y., Guo, L., Hu, L., & Yang, K. (2026). Engineered Bacteria‐Vesicle Delivered Lactate Reprogramming Boosts Tumor Radiosensitivity. Advanced Science, 13(16). https://doi.org/10.1002/advs.202524303
Vancouver
Peng F, Lei Z, Zhang Z, Su Z, Zhang C, Yang H, et al. Engineered Bacteria‐Vesicle Delivered Lactate Reprogramming Boosts Tumor Radiosensitivity. Advanced Science. 2026;13(16). doi:10.1002/advs.202524303
BibTeX
@article{Peng2026,
author = {Peng, Fei and Lei, Zhe and Zhang, Zhehao and Su, Zhiyue and Zhang, Chonghai and Yang, Huan and Liu, Shu and Hu, Mengyuan and Wang, Yuhong and Guo, Lingchuan and Hu, Lin and Yang, Kai},
title = {Engineered Bacteria‐Vesicle Delivered Lactate Reprogramming Boosts Tumor Radiosensitivity},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {16},
doi = {10.1002/advs.202524303}
}
EUVIMED